Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 10 May 2012 | By Alexander Gaffney, RAC
The number of inspections conducted by the US Food and Drug Administration (FDA) is increasingly rapidly as the agency moves to crack down on violators of quality regulations, the Director of FDA's supplement program said, reports Natural Products Insider.
Daniel Fabricant, director of FDA's Division of Dietary Supplement Programs, said the agency is starting to use its authorities more aggressively-something Regulatory Focus took note of in April 2012 and May 2012.
Fabricant said in April he was "aghast at the degree of non-compliance" with current good manufacturing practices (cGMPs), and added the agency was "seeing some of the same mistakes from warning letter to warning letter."
"That's concerning," Fabricant said at the time.
Fabricant added to those remarks while attending the American Herbal Products Association's Botanical Congress in May, explaining the agency plans to continue an aggressive push against quality infractions.
"It won't be the last time we use those authorities," said Fabricant. "It's something to be mindful of. It's something we take very seriously, as you've seen from the actions."
Companies are frequently violating the same cGMP regulations, said Fabricant, including failing to establish batch records, specifications, manufacturing records, quality control procedures or quality assurance procedures.
"GMPs (are) the biggest challenge ... facing the dietary supplement industry, at least that's the way the regulators see it, and we hope everyone understands that," Fabricant said.
Read more:
Natural Products Insider - FDA Will Increase Inspections, Product Seizures
Regulatory Focus - FDA 'Aghast' at Lack of cGMP, AER Compliance by Supplement Manufacturers
Regulatory Focus - Six Dietary Supplement Manufacturers Cited by FDA for Promoting Unproven Claims, cGMP Violations
Regulatory Focus - FDA Sends out Warning Letters to Supplement Manufacturers
Tags: Supplement, Fabricant, Supplements, CGMPs, Latest News, cGMP, warning letters, enforcement, inspections
Regulatory Focus newsletters
All the biggest regulatory news and happenings.